Founded Year
2003Stage
Series A | AliveTotal Raised
$3.7MLast Raised
$3.7M | 19 yrs ago
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Imagine Pharmaceuticals Patents
Imagine Pharmaceuticals has filed 4 patents.
The 3 most popular patent topics include:
- Diabetes
- Carboxylic acids
- Fluoroarenes
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
7/17/2020 | 3/28/2023 | Diabetes, Insulin therapies, Fluoroarenes, Hypolipidemic agents, Carboxylic acids | Grant |
Application Date | 7/17/2020 |
|---|---|
Grant Date | 3/28/2023 |
Title | |
Related Topics | Diabetes, Insulin therapies, Fluoroarenes, Hypolipidemic agents, Carboxylic acids |
Status | Grant |
Imagine Pharmaceuticals Frequently Asked Questions (FAQ)
When was Imagine Pharmaceuticals founded?
Imagine Pharmaceuticals was founded in 2003.
Where is Imagine Pharmaceuticals's headquarters?
Imagine Pharmaceuticals's headquarters is located at 9393 Towne Centre Drive, San Diego.
What is Imagine Pharmaceuticals's latest funding round?
Imagine Pharmaceuticals's latest funding round is Series A.
How much did Imagine Pharmaceuticals raise?
Imagine Pharmaceuticals raised a total of $3.7M.
Who are the investors of Imagine Pharmaceuticals?
Investors of Imagine Pharmaceuticals include Domain Associates, Forward Ventures and Research Corporation Technologies.
Who are Imagine Pharmaceuticals's competitors?
Competitors of Imagine Pharmaceuticals include Erydel, Chiasma, Impel Pharmaceuticals, Brainsgate, OptiNose and 11 more.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Compare Imagine Pharmaceuticals to Competitors
Transdermal delivery of drugs and cosmetic agents utilizing active-patch technology. The company was acquired by Teikoku.
Travanti offers transdermal delivery of drugs and cosmetic agents utilizing active-patch technology.
FORMAC is a pharmaceutical R&D company engaged in drug delivery and development. The firm aims to increase pharmaceutical R&D productivity and product value by enhancing the performance of (pre)clinical drug candidates and marketed drugs.
Launched in July of 2000, the Westfield Life Sciences Fund invests in healthcare companies across the capitalization spectrum including medical devices, drugs, drug delivery, biotechnology, and healthcare services. Portfolio manager Will Muggia employs a fundamental, bottom up research driven process that focuses on preservation of capital and long-term outperformance. Westfield's industry network developed by Mr. Muggia and his analytical team is critical to new idea generation.
Pantec Biosolutions is a provider of transdermal drug delivery solutions.
Replenish Inc is a Pasadena, Calif.-based developer of a drug delivery platform.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
